Evidence map›Paper›PMID 41910793›Full record

ArticleArchives of microbiology2026

Construction and characterization of the first Arcobacter butzleri - Escherichia coli shuttle vector.

Adrián Salazar-Sánchez, Rodrigo Alonso, Aurora Fernández-Astorga, Ilargi Martínez-Ballesteros, Irati Martinez-Malaxetxebarria

Abstract read
In one paragraph

Article in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Adrián Salazar-SánchezMikroIker Research Group, Department of Immunology, Microbiology, and Parasitology, Faculty of Pharmacy, University of the Basque Country EHU, Paseo de la Universidad 7, 01006, Vitoria-Gasteiz, Spain.ORCID http://orcid.org/0000-0002-2454-4753
Rodrigo AlonsoMikroIker Research Group, Department of Immunology, Microbiology, and Parasitology, Faculty of Pharmacy, University of the Basque Country EHU, Paseo de la Universidad 7, 01006, Vitoria-Gasteiz, Spain.ORCID http://orcid.org/0000-0002-8129-4850
Aurora Fernández-AstorgaMikroIker Research Group, Department of Immunology, Microbiology, and Parasitology, Faculty of Pharmacy, University of the Basque Country EHU, Paseo de la Universidad 7, 01006, Vitoria-Gasteiz, Spain.ORCID http://orcid.org/0000-0003-0509-3093
Ilargi Martínez-BallesterosMikroIker Research Group, Department of Immunology, Microbiology, and Parasitology, Faculty of Pharmacy, University of the Basque Country EHU, Paseo de la Universidad 7, 01006, Vitoria-Gasteiz, Spain.ORCID http://orcid.org/0000-0002-8867-1487
Irati Martinez-MalaxetxebarriaMikroIker Research Group, Department of Immunology, Microbiology, and Parasitology, Faculty of Pharmacy, University of the Basque Country EHU, Paseo de la Universidad 7, 01006, Vitoria-Gasteiz, Spain. irati.martinez@ehu.eus.ORCID http://orcid.org/0000-0002-6576-6707

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study addresses a key limitation in the genetic characterisation of Arcobacter butzleri, an emerging food- and waterborne pathogen associated with gastrointestinal and systemic infections in humans and animals. Despite the identification of numerous putative virulence genes, functional validation has been hindered by the absence of suitable complementation tools. Here, we report the development and characterisation of the first shuttle vector capable of replication in both Escherichia coli and A. butzleri. A total of 117 A. butzleri isolates were screened for plasmids, leading to the identification and sequencing of a novel cryptic plasmid, pABRW13 (3,402 bp), from a waterborne strain. This plasmid revealed four open reading frames, including a putative replication-associated gene. These elements were incorporated into a novel shuttle vector, pIMM24 (7,425 bp), together with a tetracycline resistance cassette (tetO), using the pBluescript KS derivative pMW2 vector as backbone. The resulting construct successfully replicated in both hosts, exhibited stable maintenance in E. coli and moderate stability in A. butzleri, and conferred increased tetracycline resistance. Functional validation was achieved by complementation of a fliS knockout mutant, restoring motility to near wild-type levels. Overall, pIMM24 represents a significant advancement in the genetic toolkit available for A. butzleri, enabling gene complementation studies and facilitating deeper insights into its physiology and pathogenic mechanisms.

Indexed as

ArcobacterEscherichia coliGenetic VectorsGenetic Complementation TestOpen Reading FramesPlasmidsArcobacter butzleriGene function restorationGenetic complementationShuttle vector

Identifiers

PMID41910793
PMCPMC13035637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.